Cargando…

Identification of spleen tyrosine kinase as a potential therapeutic target for esophageal squamous cell carcinoma using reverse phase protein arrays

The vast majority of esophageal cancers in China, India and Iran are esophageal squamous cell carcinomas (ESCC). A timely diagnosis provides surgical removal as the main therapeutic option for patients with ESCC. Currently, there are no targeted therapies available for ESCC. We carried out reverse p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Barbhuiya, Mustafa A., Kashyap, Manoj K., Puttamallesh, Vinuth N., Kumar, Rekha Vijay, Wu, Xinyan, Pandey, Akhilesh, Gowda, Harsha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5915082/ https://www.ncbi.nlm.nih.gov/pubmed/29719615 http://dx.doi.org/10.18632/oncotarget.24853

Ejemplares similares

Phosphotyrosine profiling identifies ephrin receptor A2 as a potential therapeutic target in esophageal squamous‐cell carcinoma
por: Syed, Nazia, et al.
Publicado: (2015)

Quantitative Proteomics of Urinary Bladder Cancer Cell Lines Identify UAP1 as a Potential Therapeutic Target
por: Puttamallesh, Vinuth N., et al.
Publicado: (2020)

Downregulation of S100 Calcium Binding Protein A9 in Esophageal Squamous Cell Carcinoma
por: Pawar, Harsh, et al.
Publicado: (2015)

An integrated approach for identification of a panel of candidate genes arbitrated for invasion and metastasis in oral squamous cell carcinoma
por: Routray, Samapika, et al.
Publicado: (2021)

Phosphoproteomic Profiling Identifies Aberrant Activation of Integrin Signaling in Aggressive Non-Type Bladder Carcinoma
por: Deb, Barnali, et al.
Publicado: (2019)

Molecular Characterization of Esophageal Squamous Cell Carcinoma Using Quantitative Proteomics
por: Mangalaparthi, Kiran K., et al.
Publicado: (2023)

Expression, regulation and targeting of receptor tyrosine kinases in esophageal squamous cell carcinoma
por: Kashyap, Manoj Kumar, et al.
Publicado: (2018)

Proteomic profiling of serum samples from chikungunya-infected patients provides insights into host response
por: Puttamallesh, Vinuth N, et al.
Publicado: (2013)

Mutational Landscape of Esophageal Squamous Cell Carcinoma in an Indian Cohort
por: Mangalaparthi, Kiran K., et al.
Publicado: (2020)

Overexpression of Periostin and Lumican in Esophageal Squamous Cell Carcinoma
por: Kashyap, Manoj Kumar, et al.
Publicado: (2010)

The non-receptor tyrosine kinase TNK2/ACK1 is a novel therapeutic target in triple negative breast cancer
por: Wu, Xinyan, et al.
Publicado: (2016)

Phosphoproteomics of Retinoblastoma: A Pilot Study Identifies Aberrant Kinases
por: Selvan, Lakshmi Dhevi Nagarajha, et al.
Publicado: (2018)

A dual specificity kinase, DYRK1A, as a potential therapeutic target for head and neck squamous cell carcinoma
por: Radhakrishnan, Aneesha, et al.
Publicado: (2016)

Corrigendum: A dual specificity kinase, DYRK1A, as a potential therapeutic target for head and neck squamous cell carcinoma
por: Radhakrishnan, Aneesha, et al.
Publicado: (2017)

Global phosphotyrosine survey in triple-negative breast cancer reveals activation of multiple tyrosine kinase signaling pathways
por: Wu, Xinyan, et al.
Publicado: (2015)

Proteomic analysis of purified protein derivative of Mycobacterium tuberculosis
por: Prasad, Thottethodi Subrahmanya Keshava, et al.
Publicado: (2013)

Host response profile of human brain proteome in toxoplasma encephalitis co-infected with HIV
por: Sahu, Apeksha, et al.
Publicado: (2014)

Proteogenomic analysis of pathogenic yeast Cryptococcus neoformans using high resolution mass spectrometry
por: Nagarajha Selvan, Lakshmi Dhevi, et al.
Publicado: (2014)

Chronic exposure to cigarette smoke leads to activation of p21 (RAC1)-activated kinase 6 (PAK6) in non-small cell lung cancer cells
por: Raja, Remya, et al.
Publicado: (2016)

Quantitative Tyrosine Phosphoproteome Profiling of AXL Receptor Tyrosine Kinase Signaling Network
por: Wu, Xinyan, et al.
Publicado: (2021)

Seroprevalence of Lymes disease in the Nagarahole and Bandipur forest areas of South India
por: Babu, Kalpana, et al.
Publicado: (2020)

Role of spleen tyrosine kinase in liver diseases
por: Kurniawan, Dhadhang Wahyu, et al.
Publicado: (2020)

Signaling Network Map of Endothelial TEK Tyrosine Kinase
por: Khan, Aafaque Ahmad, et al.
Publicado: (2014)

Icotinib derivatives as tyrosine kinase inhibitors with anti-esophageal squamous carcinoma activity
por: Chen, Xiaojie, et al.
Publicado: (2022)

Targeting Spleen Tyrosine Kinase-Bruton's Tyrosine Kinase Axis for Immunologically Mediated Glomerulonephritis
por: Chen, Jin-Shuen, et al.
Publicado: (2014)

Targeting focal adhesion kinase overcomes erlotinib resistance in smoke induced lung cancer by altering phosphorylation of epidermal growth factor receptor
por: Solanki, Hitendra S., et al.
Publicado: (2018)

Correction: Targeting focal adhesion kinase overcomes erlotinib resistance in smoke induced lung cancer by altering phosphorylation of epidermal growth factor receptor
por: Solanki, Hitendra S., et al.
Publicado: (2021)

Molecular and clinical studies in 107 Noonan syndrome affected individuals with PTPN11 mutations
por: Athota, Jeevana Praharsha, et al.
Publicado: (2020)

Spleen Tyrosine Kinase Inhibition Modulates p53 Activity
por: Althubiti, Mohammad
Publicado: (2017)

An inhibitor of spleen tyrosine kinase suppresses experimental crescentic glomerulonephritis
por: Han, Yingjie, et al.
Publicado: (2018)

Prognostic value of spleen tyrosine kinase in human solid tumors
por: Ni, Beibei, et al.
Publicado: (2018)

Alzheimer’s disease pathological lesions activate the spleen tyrosine kinase
por: Schweig, Jonas Elias, et al.
Publicado: (2017)

Prognostic Impact of Array-based Genomic Profiles in Esophageal Squamous Cell Cancer
por: Carneiro, Ana, et al.
Publicado: (2008)

Spleen stiffness determined by spleen-dedicated device accurately predicted esophageal varices in cirrhosis patients
por: Liu, Jiqing, et al.
Publicado: (2023)

FMS-Related Tyrosine Kinase 3 Ligand Promotes Radioresistance in Esophageal Squamous Cell Carcinoma
por: Zhu, Zuoquan, et al.
Publicado: (2021)

Spleen tyrosine kinase inhibition in the treatment of autoimmune, allergic and autoinflammatory diseases
por: Pamuk, Omer N, et al.
Publicado: (2010)

Spleen Tyrosine Kinase Mediates Microglial Activation in Mice With Diabetic Retinopathy
por: Liu, Xiaozhe, et al.
Publicado: (2021)

Spleen tyrosine kinase inhibition restores myeloid homeostasis in COVID-19
por: Wigerblad, Gustaf, et al.
Publicado: (2023)

Spleen tyrosine kinase (SYK) signals are implicated in cardio-cerebrovascular diseases
por: Li, Mohan, et al.
Publicado: (2023)

Immunomodulatory role of spleen tyrosine kinase in chronic inflammatory and autoimmune diseases
por: Zhou, Yaqi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_861eq8uu6bbampg56h23uj5uep